Company profile for Laekna Therapeutics

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Founded in December 2016, Laekna Therapeutics is a startup biotech company focusing on innovative drug discovery and development, we are dedicated to developing new targeted therapies to treat cancer and liver diseases. Laekna has strong expertise in both small molecule and antibody discovery and development. Drs. Chris Lu and Yong Yue, and the rest of the leadership team have extensive R&D and management experience in global...
Founded in December 2016, Laekna Therapeutics is a startup biotech company focusing on innovative drug discovery and development, we are dedicated to developing new targeted therapies to treat cancer and liver diseases. Laekna has strong expertise in both small molecule and antibody discovery and development. Drs. Chris Lu and Yong Yue, and the rest of the leadership team have extensive R&D and management experience in global pharmaceutical companies, along with an exceptional track record of new drug approval and marketing. Laekna is a company full of energy and innovation.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
China
Address
Address
5th Floor, 987 Cailun Road, Zhangjiang, Pudong, Shanghai
Telephone
Telephone
+86(21)50716089
Linkedin
Linkedin
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

DCAT Week

DCAT Week

Not Confirmed

envelop Contact Supplier

DCAT Week

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.businesswire.com/news/home/20250623952873/en/ADA-2025-Laekna-Presented-Clinical-and-Pre-clinical-Studies-Results-of-LAE102-LAE103-and-LAE123

BUSINESSWIRE
23 Jun 2025

https://www.businesswire.com/news/home/20250303151589/en

BUSINESSWIRE
03 Mar 2025

https://en.laekna.com/new/431.html

PRESS RELEASE
21 Nov 2024

https://www.prnewswire.com/news-releases/laekna-announces-fda-approval-for-the-phase-iii-clinical-trial-protocol-of-lae002-afuresertib-plus-lae001-for-the-treatment-of-prostate-cancer-302154036.html

PR NEWSWIRE
23 May 2024

https://www.prnewswire.com/news-releases/laekna-announces-two-poster-presentations-on-internally-discovered-drug-candidates-at-aacr-2024-302109861.html

PR NEWSWIRE
07 Apr 2024

https://www.prnewswire.com/news-releases/health-latest-news/pharmaceuticals-list/

PR NEWSWIRE
03 Jan 2024

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty